General
FDA lifts black box warning on smoking cessation drug
 

FDA lifts black box warning on smoking cessation drug

Shared by:

 
Pfizer’s varenicline has been reported to cause adverse mental health effects including suicidal tendencies, but the FDA has opted to rescind its most severe “black box” warning on the drug due to a new study by Pfizer.
 
today.mims.com
 
21 Dec 2016 - General
 
The US Food and Drug Administration (FDA) has made an unprecedented move to remove a serious warning from the label of Pfizer’s smoking cessation treatment. The controversial drug, varenicline, was approved a decade ago and has since been the subject...
 (Total 42 words)